A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite

Snakebite is a life-threatening neglected tropical disease that is currently treated using different antibody-based antivenoms, each effective against bites of specific snake species, but not others. Here, the authors show that a combination of two toxin-inhibiting repurposed drugs provides broad pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laura-Oana Albulescu, Chunfang Xie, Stuart Ainsworth, Jaffer Alsolaiss, Edouard Crittenden, Charlotte A. Dawson, Rowan Softley, Keirah E. Bartlett, Robert A. Harrison, Jeroen Kool, Nicholas R. Casewell
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/c846bd63ad3c41699aff8d93671d6bf1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c846bd63ad3c41699aff8d93671d6bf1
record_format dspace
spelling oai:doaj.org-article:c846bd63ad3c41699aff8d93671d6bf12021-12-02T13:57:55ZA therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite10.1038/s41467-020-19981-62041-1723https://doaj.org/article/c846bd63ad3c41699aff8d93671d6bf12020-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-19981-6https://doaj.org/toc/2041-1723Snakebite is a life-threatening neglected tropical disease that is currently treated using different antibody-based antivenoms, each effective against bites of specific snake species, but not others. Here, the authors show that a combination of two toxin-inhibiting repurposed drugs provides broad protection in experimental animals against the lethal effects of snakebites from multiple snake species.Laura-Oana AlbulescuChunfang XieStuart AinsworthJaffer AlsolaissEdouard CrittendenCharlotte A. DawsonRowan SoftleyKeirah E. BartlettRobert A. HarrisonJeroen KoolNicholas R. CasewellNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Laura-Oana Albulescu
Chunfang Xie
Stuart Ainsworth
Jaffer Alsolaiss
Edouard Crittenden
Charlotte A. Dawson
Rowan Softley
Keirah E. Bartlett
Robert A. Harrison
Jeroen Kool
Nicholas R. Casewell
A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite
description Snakebite is a life-threatening neglected tropical disease that is currently treated using different antibody-based antivenoms, each effective against bites of specific snake species, but not others. Here, the authors show that a combination of two toxin-inhibiting repurposed drugs provides broad protection in experimental animals against the lethal effects of snakebites from multiple snake species.
format article
author Laura-Oana Albulescu
Chunfang Xie
Stuart Ainsworth
Jaffer Alsolaiss
Edouard Crittenden
Charlotte A. Dawson
Rowan Softley
Keirah E. Bartlett
Robert A. Harrison
Jeroen Kool
Nicholas R. Casewell
author_facet Laura-Oana Albulescu
Chunfang Xie
Stuart Ainsworth
Jaffer Alsolaiss
Edouard Crittenden
Charlotte A. Dawson
Rowan Softley
Keirah E. Bartlett
Robert A. Harrison
Jeroen Kool
Nicholas R. Casewell
author_sort Laura-Oana Albulescu
title A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite
title_short A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite
title_full A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite
title_fullStr A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite
title_full_unstemmed A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite
title_sort therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/c846bd63ad3c41699aff8d93671d6bf1
work_keys_str_mv AT lauraoanaalbulescu atherapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT chunfangxie atherapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT stuartainsworth atherapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT jafferalsolaiss atherapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT edouardcrittenden atherapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT charlotteadawson atherapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT rowansoftley atherapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT keirahebartlett atherapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT robertaharrison atherapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT jeroenkool atherapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT nicholasrcasewell atherapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT lauraoanaalbulescu therapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT chunfangxie therapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT stuartainsworth therapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT jafferalsolaiss therapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT edouardcrittenden therapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT charlotteadawson therapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT rowansoftley therapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT keirahebartlett therapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT robertaharrison therapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT jeroenkool therapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
AT nicholasrcasewell therapeuticcombinationoftwosmallmoleculetoxininhibitorsprovidesbroadpreclinicalefficacyagainstvipersnakebite
_version_ 1718392285844996096